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Abstract
AIMS: COVID-19 is a new virus which has spread to most countries in the world. Many papers have been published 
on the clinical manifestations of this virus. This paper concentrates only on the clinical cases and prognosis of 
COVID-19 presented in the literature.
METHODS: Systematic review is done, and taken into consideration, all published papers in the literature related to 
COVID-19. Inclusion and exclusion criteria have been applied.
RESULTS: Few papers have been determined after many filtrations of all published papers concerning inclusion 
and exclusion criteria to assess outcome of existing COVID-19. Most published papers or reports did not provide full 
details for each case.
CONCLUSION: Most clinical description data in these reports are so limited and missing some of the critical 
elements such as the date of infection, source of infection, symptoms, diagnostic criteria, incubation of infection, 
transmission of infection, number of identified cases after contact with infected patients, and health workers are 
affected or not by treatment of infected patients, patient age, and type of study. No clear evidence of the treatment 
plan and the prevention and most data in literature depending on personal experience only which is different from 
country to others.
Edited by: Mirko Spiroski
Citation: Tarakji B, Alali FM, Alenzi A, Nassani MZ. 
Systematic Review with no Meta-analysis of Coronavirus 
COVID-19. Open Access Maced J Med Sci. 2020 Jun 30; 
8(T1):108-111. https://doi.org/10.3889/oamjms.2020.4873
Keywords: COVID-19; Coronavirus; Clinical 
manifestations; Prognosis
 *Correspondence: Dr. Bassel Tarakji, Department of 
Maxillofacial Surgery and Diagnostic Sciences, Prince 
Sattam Bin Abdulaziz University, College of Dentistry, Al 
Kharj, Saudi Arabia. E-mail: b.tarakji@psau.edu.sa
Received: 01-May-2020
Revised: 03-Jun-2020
Accepted: 04-Jun-2020
Copyright: © 2020 Bassel Tarakji, Faisal Mehsen Alali, 
Adel Alenzi, Mohammad Zakaria Nassani
Funding: Publication of this article was financially 
supported by the Scientific Foundation SPIROSKI, Skopje, 
Republic of Macedonia
Competing Interest: The authors have declared that no 
competing interest exists
Open Access: This is an open-access article distributed 
under the terms of the Creative Commons Attribution-
NonCommercial 4.0 International License (CC BY-NC 
4.0)
Introduction
SARS-CoV-2 was identified as the causative 
factor of outbreak of respiratory disease, now named 
COVID-19 [1].
The virus did not cause illness in humans 
before [2]. This virus caused pneumonia of unknown 
etiology in Wuhan, China [3], [4], 27 out of 41 confirmed 
cases had direct exposure to the Wuhan seafood market 
where is believed the animal source of infection [5]. 
The transmission of COVID-19 from person to person 
has been confirmed [6]. The infected patients have 
identified in China, then the infection is spreading to 
many countries in the world [7]. The number of infected 
patients is increased daily. There is limited number 
of publication in literature due to the discovery of this 
COVID-19 as new virus. The aim of this study is to do 
systematic review of the available published data of 
COVID-19, also to highlight the most important clinical 
data only concerning on COVID to assess the prognosis 
of this new virus.
Materials and Methods
A literature search using MEDLINE, accessed 
through the National Library of Medicine, PubMed, 
EMBASE, and Cochrane systematic review interface, 
from 2019 to 2020 for articles relating to COVID-19 
written in the English language. Various terms were 
used for the search: Coronavirus; COVID-19.
Inclusion criteria
All published articles or clinical report 
concerning COVID-19. Only clinical data written in 
English language will be included such as type of study, 
place of existing infection, gender, diagnostic criteria 
to detect COVID-19, number of confirmed cases, 
symptoms, and management.
Exclusion criteria
Articles includes non-clinical data such as 
pathogenesis, route of transmission, and other types of 
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coronavirus will be excluded. Duplicated clinical data 
will be excluded as well.
Results
A total of 984 papers have been identified. We 
have reviewed the full text of those papers, after many 
filtration of those papers after reading abstract and full 
papers, 6 out of 984 were identified and included to be 
consistent with the inclusion and exclusion criteria.
Table 1 summarizes the clinical data for the 
selected papers, Bordi et al. [1] reported that 126 
suspected patients have undergone for COVID-19 test 
in Rome. They indicated that 3 out of 126 patients had 
confirmed COVID-19. They mentioned that the positive 
test of the respiratory pathogens might be related to 
other virus such as influenza. They advised to use a 
broad-spectrum molecular diagnostic for fast detection 
of this new virus.
Chen et al. [4] indicated that 99 patients had 
confirmed COVID-19 in China. COVID-19 was detected 
in 67 males and 32 females. The mean age was 55.5 
years. Fifty (51%) patients had chronic diseases, 
including cardiovascular endocrine system disease, 
digestive system disease, respiratory system disease, 
malignant tumor, and nervous system disease. The 
most common clinical features are cough and fever 
in 82% and 83% of patients. All the patients stay in 
hospital for isolation and 75% had undergone for 
antiviral treatment. Thirty-one (31%) patients had 
been discharged, 11 (11%) were died. Two out 11 died 
patients had no history of chronic disease but they were 
smokers. Nine out 11 of patients who died, five were 
older than 60 years, three had hypertension, and one 
was heavy smoker. They highlighted that the reduction 
in lymphocytes value in most infected patients indicated 
that COVID-19 causes damage for the immune cells 
and blocks the body cellular immune function.
Stoecklin et al. [8] reported that three cases 
confirmed COVID-19 in France. First, the patient 
complains of fever, headaches, and cough; second, the 
patient develops of fever, chills, fatigue, conjunctivitis, and 
cough; and third, the patient develops fever, chills, fatigue, 
and cough. Patients age was 30-31  and 48 years old.
Patel and Jernigan [9] reported that 11 cases 
were identified in the USA with COVID-19. The patients 
age ranges from 20 to 60. Patients complain of fever, 
cough, or sore throat and no death reported.
National Emergency Response Center, 
Epidemiology, and Case Management Team [10] indicated 
to 28 cases detected in South Korea with COVID-19. 
Patients age ranges from 20 to 79. They complained of 
fever, sore throat, cough, chills, muscle, and ache.
Spiteri et al. [11] reported that 38 cases 
confirmed with COVID-19. The symptoms were fever, 
cough, weakness, headaches, sore throat, rhinorrhea, 
and shortness of breath.
Discussion
COVID-19 is a danger virus which can spread 
from human to human. The COVID-19 virus spreads 
primarily through droplets of saliva or discharge 
from the nose when an infected person coughs or 
sneezes [6], [7]. These infected droplets can spread 1–2 
m and deposit on surfaces. COVID-19 is transmitted 
either by inhalation of these droplets or touching surfaces 
contaminated by patient and touching the nose, mouth, 
and eyes [2], [6], [7], [12]. Most of the published articles 
or reports concerning COVID-19 missed many useful 
information to assess this virus in infected patients. 
The incubation period of this virus is 14 days [2], [12]. 
Table 1: Clinical data of case series in selected papers of some patients infected with COVID-19
Authour Type of 
study
Country N of cases Patient 
gender
Patient age Confirmed 
cases
Clinical features Outcome
Bordi et al (February 2020) Case 
report
Italay 126 
patients
Mean age 
35 (range 
1-85 years)
3 out of 126 Not mention Not mention
Chen et al (Feburary 2020) Case 
report
Jinyintan 
Hospital, 
Wuhan, 
China
99 patients Mean age 
55.5 (range 
21-82)
99 
confirmed 
cases
Fever in 83,cough,81 have cough, 31 shortness of 
breath,11 muscle ache, 9 confusion,8 headache, 5 sore 
throat, 4 rhinorrhoea,2 chest pain,2 Diarhoea,  1nausea 
and vomiting
31 discharge, 
11 died, all 
other patients 
were still in 
hospital
 Stoecklin et al (January 
2020)
Case 
report
France 3 cases 48, 31, 30 3 cases 
confirmed
First patient complains of fever, headaches and cough, 
second patient develops of fever, chills, fatigue, 
conjunctivitis and cough, third patient develops  fever, 
chills, fatigue and cough
Not reported
Patel et al (2020) Case 
report
Unted 
States
11 cases Range age 
20-60
11 
confirmed 
cases
fever, cough, or sore throat No death 
reported
 National Emergency 
Response Center, 
Epidemiology and Case 
Management Team (2020)
Case 
report
South 
Korea
28 cases Range 
20-79
28 
confirmed 
cases
Fever , sore throat, cough,chills,muscle ache Not reported
Spiteri et al (2020) Case 
report
Europe 38 cases 2-81 38 
confirmed 
cases
Fever, cough,weakness,headaches,sore throat, 
Rhinorrhoea, Shortness of breath
One patient 
died
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Some patients infected with the COVID-19 virus with 
mild-to-moderate respiratory illness showed recovery 
without requiring special treatment [12]. Older people, 
compromised patients such as cardiovascular disease, 
diabetes, chronic respiratory disease, and cancer are 
more likely to show bad prognosis [2], [3], [12]. In 
another study, nine pregnant women [13] infected with 
COVID-19, there was no transmission of COVID-19 to 
their new born babies. The World Health Organization 
(WHO) indicates to protect yourself by washing hands 
and used alcohol based rub frequently and not touching 
face [7]. The most common symptoms of COVID-19 
are fever and cough [3], [4], [10]. Some patients may 
have aches and pains, nasal congestion, runny nose, 
sore throat, or diarrhea. You can catch COVID-19 from 
patients looks not ill or with mild symptoms [7]. It is 
recommended to keep at least 1 m (3 feet) distance 
between yourself and anyone who is coughing or 
sneezing [3], [7]. Also use tissue to cover your eye 
and nose when you are coughing or sneezing [7]. 
The WHO is mentioned [7] to avoid contamination of 
uncooked foods. The recommended method of COVID-
19 is nucleic acid detection in the nasal and throat 
swab sampling or other respiratory tract samplings by 
real-time PCR [3], [12]. Furthermore, throat swabs test 
shows positive in the 1st day of infection and by contrast, 
rectal swabs show positive in the latter period of 
infection [14]. We declare from our extensive reading in 
literature that false negative results in detection COVID-
19 in some patients although its presence in body. 
These false negative result due to different reasons 
such as an improper collection of sputum samples, 
inhomogeneous sputum, contamination of the collected 
sample, ignorance of viral load due to the early stages 
of the infection, inappropriate diagnostic kits, sampling 
from inappropriate site of the throat in the throat swab, 
no good training and skills, and poor experience. 
There is no specific antiviral treatment recommended 
for COVID-19, and no vaccine is currently available. 
The treatment is symptomatic, and oxygen therapy 
represents the major treatment intervention for patients 
with severe infection. Immunocompromised patients 
should avoid public exposure. Despite the limitations 
of this study it highlighted the most critical issues 
concerning COVID-19. The clinical manifestations of 
COVID-19, determination of route of transmission for 
COVID-19, diagnostic tools of COVID-19, prevention 
and modalities of treatment, following up of infected 
patients for long term after recovery, are essential 
points to be considered in any future research in order 
to obtain more valid results about the nature and 
behavior of COVID-19.  
. There is no clear international plan to stop 
spreading this virus as it spreads in more than 100 
countries in the world. The current available plan is to 
stay home in all countries specially those which have 
many patients confirmed COVID-19. Although China 
has made a great progress in stop this virus and many 
patients showed a good recovery, this needs follow-up 
of the previous cases to avoid secondary infection and 
to do full screening for all healthy people that contact 
with infected patients. This international pandemic 
COVID-19 showed that there is lack of education for 
public to deal with any danger disease-like COVID. The 
only available data in literature are case series. We 
believe that the number of infected patients in some 
countries is not reliable and needs hard work from 
the WHO to evaluate and confirm the cases number. 
Most published data on COVID-19 need to differentiate 
between mild, moderate, and severe cases that need 
to refer to hospital. We have noticed poor information 
about the died patients infected with this virus. No long 
follow-up for patients get recovery. Recurrent cases of 
COVID-19 should highlight. The WHO should educate 
the health workers over the world with strict criteria to 
detect this virus and avoid transmission the virus to 
them.
Conclusion
This virus outbreak has challenged the 
economic, medical, and public health infrastructure, 
of the most countries in the world. Strict procedures 
should be taken in the near future to avoid outbreak of 
this virus of zoonotic origin. People over the world are 
looking for finding new vaccination to avoid this virus 
and the best treatment to save their life.
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